HUTCHMED (China) (HCM) Non-Current Deferred Tax Liability (2014 - 2025)

HUTCHMED (China)'s (HCM) quarterly Non-Current Deferred Tax Liability came in at $255000.0 in Q4 2025, down 91.47% year-on-year from $3.0 million in Q4 2024, and down 91.47% on a QoQ basis from $3.0 million in Q4 2024.

HUTCHMED (China) (HCM) Non-Current Deferred Tax Liability (2014 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 12 years of Non-Current Deferred Tax Liability data on file, last reported at $255000.0 in Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 91.47% year-over-year to $255000.0 in Q4 2025; TTM through Dec 2025 was $255000.0, a 91.47% decrease from a year earlier, with the FY2025 full-year figure at $255000.0, down 91.47% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 stood at $255000.0, down from $3.0 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for HCM reached as high as $3.0 million in Q4 2024 and fell as low as $255000.0 in Q4 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $2.0 million across 5 years, with a median of $2.7 million in 2022.
  • Across the five-year window, Non-Current Deferred Tax Liability soared 101.48% in 2024 and plunged 91.47% in 2025, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $2.8 million in 2021, then fell by 1.99% to $2.7 million in 2022, then sank by 45.24% to $1.5 million in 2023, then surged by 101.48% to $3.0 million in 2024, then plunged by 91.47% to $255000.0 in 2025.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $255000.0 in Q4 2025, $3.0 million in Q4 2024, and $1.5 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 HUTCHMED (China) 241.90 Mn 243.61 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 255,000.00
Dec 31, 2025 255,000.00
Dec 31, 2024 2.99 Mn
Dec 31, 2024 2.99 Mn
Dec 31, 2023 1.48 Mn
Dec 31, 2023 1.48 Mn
Dec 31, 2022 2.71 Mn
Dec 31, 2022 2.71 Mn
Dec 31, 2021 2.77 Mn
Dec 31, 2021 2.77 Mn
Dec 31, 2020 3.55 Mn
Dec 31, 2020 3.55 Mn
Dec 31, 2019 2.34 Mn
Dec 31, 2019 2.34 Mn
Dec 31, 2018 4.26 Mn
Dec 31, 2018 4.26 Mn
Dec 31, 2017 3.82 Mn
Dec 31, 2017 3.82 Mn
Dec 31, 2016 4.99 Mn
Dec 31, 2016 4.99 Mn